1Bellanger AP,Grenouillet F,Henon T,et al.Retrospective assessment of β-D-(1,3)-glucan for presumptive diagnosis of fungal infections[J].APMIS,2011,119(4/5):280-286.
2Kedzierska A,Kochan P,Pietrzyk A,et al.Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans:galactomannan,mannan and (1,3)-beta-D-glucan antigens[J].Eur J Clin Microbiol Infect Dis,2007,26(11):755-766.
3Odabasi Z,Mattiuzzi G,Estey E,et al.β-D-glucan as a diagnostic adjunct for invasive fungal infections:validation,cut off development,and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome[J].Clin Infect Dis,2004,39(2):199-205.
4Pazos C,Ponton J,Palacio AD.Contribution of (1-3)-β-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients:a comparison with serial screening for circulating galactomannan[J].J Clin Microbiol,2005,43(1):299-305.
5Feldmesser M,Kress Y,Mednick A,et al.The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by cryptococcus neoformans[J].J Infect Dis,2000,182(6):1791-1795.
